WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-06-30 was $100.00K, a 85.71% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-03-31 was $100.00K, a 75.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-09-30 was -$100.00K, a 112.50% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-06-30 was $700.00K, a 250.00% increase year-over-year.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month |
|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-07-23 | $200.00K 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-04-23 | ||
| 2025-09-30 | -$100.00K 10-Q · filed 2025-10-23 | $600.00K derived: sum of 2 quarters · filed 2026-07-23 | $1.00M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $700.00K 10-Q · filed 2026-07-23 | $1.10M 10-Q · filed 2026-07-23 | |
| 2025-03-31 | $400.00K 10-Q · filed 2026-04-23 | ||
| 2024-09-30 | $800.00K 10-Q · filed 2025-10-23 | $1.00M derived: sum of 2 quarters · filed 2025-10-23 | $1.20M 10-Q · filed 2025-10-23 |
| 2024-06-30 | $200.00K 10-Q · filed 2025-07-24 | $400.00K 10-Q · filed 2025-07-24 | |
| 2024-03-31 | $200.00K 10-Q · filed 2025-04-24 | ||
| 2023-09-30 | -$200.00K 10-Q · filed 2024-10-24 | $700.00K derived: sum of 2 quarters · filed 2024-10-24 | $1.20M 10-Q · filed 2024-10-24 |
| 2023-06-30 | $900.00K 10-Q · filed 2024-07-25 | $1.40M 10-Q · filed 2024-07-25 | |
| 2023-03-31 | $500.00K 10-Q · filed 2024-04-25 | ||
| 2022-09-30 | -$13.60M 10-Q · filed 2023-10-26 | -$15.50M derived: sum of 2 quarters · filed 2023-10-26 | -$16.40M 10-Q · filed 2023-10-26 |
| 2022-06-30 | -$1.90M 10-Q · filed 2023-07-27 | -$2.80M 10-Q · filed 2023-07-27 | |
| 2022-03-31 | -$900.00K 10-Q · filed 2023-04-27 | ||
| 2021-09-30 | -$400.00K 10-Q · filed 2022-10-27 | -$500.00K derived: sum of 2 quarters · filed 2022-10-27 | -$1.10M 10-Q · filed 2022-10-27 |
| 2021-06-30 | -$100.00K 10-Q · filed 2022-07-28 | -$700.00K 10-Q · filed 2022-07-28 | |
| 2021-03-31 | -$600.00K 10-Q · filed 2022-04-28 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-10-28 | $6.00M derived: sum of 2 quarters · filed 2021-10-28 | $4.00M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $5.80M 10-Q · filed 2021-07-30 | $3.80M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | -$2.00M 10-Q · filed 2021-04-30 | ||
| 2019-09-30 | -$2.40M 10-Q · filed 2020-10-23 | -$2.50M derived: sum of 2 quarters · filed 2020-10-23 | -$2.20M 10-Q · filed 2020-10-23 |
| 2019-06-30 | -$100.00K 10-Q · filed 2020-07-24 | $200.00K 10-Q · filed 2020-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |